Managers / Q3 2024 · view latest →
Verdad Advisers, LP
CIK 0001812822 · 695 ATLANTIC AVENUE, 4TH FLOOR, BOSTON, MA, 02111 · 2022516707
Summary
Verdad Advisers, LP reported $75M in U.S.-listed holdings across 93 positions for Q3 2024.
Its largest position, BRK/B, represents 6.2% of the portfolio.
Compared with Q2 2024, the fund opened 29 new positions and exited 47.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 98.0% · $73M
- Ltd Part · 0.6% · $477,134
- Other · 0.6% · $414,164
- REIT · 0.4% · $313,992
- ETP · 0.4% · $269,000
Quarter-over-Quarter Changes full breakdown →
vs Q2 2024 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| LMTLOCKHEED MARTIN CORP | NEW | +2.3K | 2.3K | +$1M | $1M |
| RTXRTX CORPORATION | NEW | +8.3K | 8.3K | +$1M | $1M |
| MSIMOTOROLA SOLUTIONS INC | NEW | +2.0K | 2.0K | +$880,825 | $880,825 |
| CSCOCISCO SYS INC | NEW | +15.6K | 15.6K | +$827,677 | $827,677 |
| NOCNORTHROP GRUMMAN CORP | NEW | +1.5K | 1.5K | +$790,521 | $790,521 |
| VRTXVERTEX PHARMACEUTICALS INC | NEW | +1.6K | 1.6K | +$749,244 | $749,244 |
| TAT&T INC | NEW | +31.3K | 31.3K | +$687,698 | $687,698 |
| ABBVABBVIE INC | NEW | +3.4K | 3.4K | +$675,777 | $675,777 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2024
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $89M | 179 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $87M | 104 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $75M | 93 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $87M | 111 | Aug 6, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $92M | 147 | May 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $49M | 53 | Feb 9, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $65M | 51 | Nov 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $64M | 46 | Aug 9, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $50M | 38 | May 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $99M | 29 | Feb 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $69M | 25 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $106M | 28 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $122M | 34 | May 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $148M | 42 | Feb 9, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $138M | 46 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $51M | 22 | Aug 10, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $314M | 37 | May 14, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $265M | 39 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.